MonitorDirect · GrowthWatch before adding
Mahindra Manulife Manufacturing Fund
Mahindra Manulife Mutual FundEquity Schemes - Thematic Fund2.3 years
The Scheme seek to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies engaged in manufacturing theme.
- NAV
- 10.5005
- 29 Oct 2026
- 1Y
- +2.1%
- Trailing CAGR
- AUM
- ₹648.11 Cr
- 30 Sept 2026
- Volatility
- Medium
- 15.0% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · The fund beat the category median in 77% of rolling 1-year windows.
Prefer peers if · Prefer WhiteOak Capital Special Opportunities Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Fail
2.3 years - thin for judging consistency.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Pass
1.17% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -23.2%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
Watch
Navin Matta · 0.9 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 39.1% of the portfolio.
Browse category
Same-category peers are preloaded into compare when available.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 23%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+2.1%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- SI+2.0%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+3.3%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- Since inception
- +2.0%
- Calendar-day CAGR
- Excess 1Y
- +6.0%
- Category median, same plan and option
- 3Y win rate
- n/a
- Windows beating the median
- 3Y percentile
- n/a
- Vs comparable share classes
- SIP 3Y XIRR
- n/a
- Simulated monthly SIP
- Worst rolling 3Y
- n/a
- 0 daily-ending windows
- Median rolling 3Y
- n/a
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -23.2%
- Worst peak-to-trough
- Current
- -7.3%
- Below last peak
- Current spell
- 59 days
- Days below latest peak
- Time below peak
- +95%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 38 days
- 14 recovered episodes
- Longest recovery
- 429 days
- Trough to prior peak
27 Sept 2024 – 6 May 2026
Trough 3 Mar 2025 · recovered in 429 days
-23.2%
31 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-9.8%
31 Jul 2024 – 26 Sept 2024
Trough 6 Aug 2024 · recovered in 51 days
-5.6%
7 May 2026 – 18 Jun 2026
Trough 11 Jun 2026 · recovered in 7 days
-4.7%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
27
Vs category
88
Consistency
77
Risk-adjusted
16
Drawdown
42
Mean
50
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Monitor
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
- Risk-adjusted return (Sharpe) is negative over the available daily history.
Supporting reads
- The fund beat the category median in 77% of rolling 1-year windows.
Portfolio
30 Sept 2026 · 53 holdings · top 10 are 39.1%.
- Top 5
- 22.7%
- Top 10
- 39.1%
- Largest holding
- 5.4%
- Effective holdings
- 38.4
Divi's Laboratories Ltd
Healthcare
5.4%
Repo
Unspecified
4.7%
Mahindra & Mahindra Ltd
Consumer Discretionary
4.4%
Shriram Pistons & Rings Ltd
Consumer Discretionary
4.2%
Sun Pharmaceutical Industries Ltd
Healthcare
3.9%
What changed
DECISION
Status moved from HEALTHY to MONITOR.
24 Sept 2026
DECISION
Status moved from HEALTHY to MONITOR.
22 Sept 2026
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
WhiteOak Capital Special Opportunities Fund
WhiteOak Capital Mutual Fund
- 1Y
- +7.2%
- 3Y
- n/a
- Vol
- 14.7%
- Max DD
- -17.0%
- Sharpe
- 0.67
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Higher trailing returns
Caveat: Higher TER
360 ONE QUANT FUND
360 ONE Mutual Fund
- 1Y
- -8.9%
- 3Y
- +13.5%
- Vol
- 16.6%
- Max DD
- -22.4%
- Sharpe
- 0.56
- 3Y win
- +91%
- Shallower drawdown
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility
Invesco India Business Cycle Fund
Invesco Mutual Fund
- 1Y
- +7.6%
- 3Y
- n/a
- Vol
- 17.5%
- Max DD
- -16.0%
- Sharpe
- 1.08
- 3Y win
- n/a
- Shallower drawdown
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility
Mahindra Manulife Business Cycle Fund
Mahindra Manulife Mutual Fund
- 1Y
- -3.8%
- 3Y
- +16.3%
- Vol
- 15.7%
- Max DD
- -21.4%
- Sharpe
- 0.58
- 3Y win
- +100%
- Shallower drawdown
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility
HDFC Defence Fund
HDFC Mutual Fund
- 1Y
- +16.1%
- 3Y
- +35.5%
- Vol
- 24.9%
- Max DD
- -34.5%
- Sharpe
- 1.19
- 3Y win
- +100%
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown